Mayo Clinic Laboratory and pathology research roundup: July 18 - Insights
This week's research roundup feature: Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
CPT Code Update History - Mayo Clinic Laboratories
Share Print Web: mayocliniclabs.com...
Mayo Clinic Laboratory and pathology research roundup: September 26 - Insights
This week's research roundup feature: Semaglutide in HFpEF across obesity class and by body weight reduction.
Mayo Clinic Laboratory and pathology research roundup: October 3 - Insights
This week's research roundup feature: Gene fusions involving tumor protein p63 gene (TP63) occur in multiple T and B cell lymphomas and portend a dismal prognosis for patients. The function and mechanisms of TP63 fusions remain unclear, and...
Mayo Clinic Laboratory and pathology research roundup: January 17 - Insights
This week's research roundup features: Exploring gene expression profiles in primary central nervous system vasculitis
Mayo Clinic Laboratory and Pathology Research Roundup: February 27 - Insights
This week's research roundup feature: Both targeted therapies and immunotherapies provide benefit in resected Stage III melanoma. We hypothesized that the combination of targeted and immunotherapy given prior to therapeutic lymph node...
Mayo Clinic Laboratory and Pathology Research Roundup: March 19 - Insights
This week's research roundup feature: The revised 4th edition of the World Health Organization (WHO4R) classification lists myelodysplastic syndromes with ring sideroblasts (MDS-RS) as a separate entity with single lineage (MDS-RS-SLD) or...
Using Data-Driven, In-Person Discussions to Support Outreach Clients - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, speaks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton. They...
Mayo Clinic Laboratory and Pathology Research Roundup: March 5 - Insights
This week's research roundup feature: Variants of uncertain significance (VUSs) in BRCA2 are a common result of hereditary cancer genetic testing. While more than 4,000 unique VUSs, comprised of missense or intronic variants, have been...